The global epigenetic antibodies market size is calculated at USD 2.70 billion in 2025 and is expected to reach around USD 12.01 billion by 2034, growing at a CAGR of 18.04% for the forecasted period.
GEAC and RCGM remain robust, science-driven regulatory bodies committed to biosafety and public interest; constructive ...
St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.
Jonathan Henninger, an assistant professor of biological sciences, is part of a growing movement in the life sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results